Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ: DMII0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Roger Bendelac
- Employees
- 2
- Headquarters
- Fort Lauderdale, United States
- IPO year
- 2025
- Market cap
- $528.8M
- Website
- https://dmaacorp.com/
Loading DMII…
Loading profile data…Frequently asked questions about DMII
What does Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) do?
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maint...
Where does DMII trade?
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) trades on the NASDAQ Global Market.
What sector is DMII in?
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Drugs Made In America Acquisition II Corp. Ordinary Shares?
Roger Bendelac is the chief executive officer of Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII).
Where is Drugs Made In America Acquisition II Corp. Ordinary Shares headquartered?
Drugs Made In America Acquisition II Corp. Ordinary Shares is headquartered in United States.
Does DMII pay a dividend?
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMII go public?
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) completed its initial public offering in 2025.